major histocompatibility complex, class II, DQ7 | |
| Haplotypes | DQA1*03:02:DQB1*03:01 DQA1*03:03:DQB1*03:01 DQA1*04:01:DQB1*03:01 DQA1*05:05:DQB1*03:01 DQA1*06:01:DQB1*03:01 |
| Structure (See HLA-DQ) | |
| Identifiers | alpha 1 *0302 *0303 *0401 *0505 *0601 |
| Symbol(s) | HLA-DQA1 |
| EBI-HLA | DQA1*0302 |
| EBI-HLA | DQA1*0303 |
| EBI-HLA | DQA1*0401 |
| EBI-HLA | DQA1*0505 |
| EBI-HLA | DQA1*0601 |
| Identifiers | beta 1 *0301 *0304 |
| Symbol(s) | HLA-DQB1 |
| EBI-HLA | DQB1*0301 |
| EBI-HLA | DQB1*0304 |
| Shared data | |
| Locus | chr.6 6p21.31 |
HLA-DQ7 (DQ7) is an HLA-DQ serotype that recognizes the common HLA DQB1*0301[1] and the less common HLA DQB1*0304 gene products. DQ7 is a form of 'split antigen' of the broad antigen group DQ3 which also contains DQ8 and DQ9.
DQ7 is linked by haplotype to a number of DQA1 (DQ alpha chain) genes, producing in cis-haplotype form, a large number of DQ αβ isoforms. These DQ alpha chains are also known to form transhaplotype isomers with other HLA-DQ.
DQ7 is linked to the following alpha chains genes (DQA1*)
| DQB1* | DQ7 | DQ3 | DQ8 | Sample |
| allele | % | % | % | size (N) |
| 0301 | 85 | 40 | 1 | 12220 |
| 0304 | 40 | 35 | 8 | 111 |
Serotyping efficiency. The serotyping efficiency of DQ7 toward DQB1*0301 is reasonably good, but still results in some false negatives, for *0304 the typing efficiency is poor and cross-reaction with DQ8 is relatively high.
DQB1*0301 is the major DQ7 alleleDQB1*0301 appears to be associated with lupus anticoagulant.[3]
DQB1*0304 is the minor DQ7 allele
| freq | |||
| ref. | Population | (%) | |
| Chukotka Chukchi (Siberia) | 26.7 | ||
| Chukotka Eskimos (Siberia) | 25.0 | ||
| Koryaks (NE Kamchatka, Siberia) | 19.1 | ||
| Polygus Evenks (Siberia) | 11.4 | ||
| Khalkh (Ulaanbaatar, Mongolia) | 11.0 | ||
| Negidal (Siberia) | 9.6 | ||
| Kushun Buryat (Siberia) | 8.0 | ||
| Tarialan Khoton (Mongolia) | 7.8 | ||
| France Ceph | 6.0 | ||
| Russia Tuva (2) | 6.0 | ||
| Udegeys Gvaysugi (Siberia) | 4.8 | ||
| Irkutsk Tofalar (Siberia) | 4.7 | ||
| Ulchi (Siberia) | 4.1 | ||
| Belgian pop2 | 4.1 | ||
| England Caucasoid | 4.0 | ||
| Italy pop 2 | 2.8 | ||
| Russia Tuva Todja | 2.3 | ||
| China Ürümqi Kazak | 2.4 | ||
| Sulamai Kets (Siberia) | 2.3 | ||
| Russia Siberia Nganasan Dudinka | 2.1 | ||
| NW Slavic Russia | 2.0 | ||
| Japan Fukuoka | 1.2 | ||
| Japan (2) | 1.1 |
DQ haplotypes of this serotype are formed between the cis-chromosomal genes of the DQA1 locus.This includes DQA1*0301, *0302, *0303, *0401, *0505, *0601.
There is a rather large degree of disequilibration about DQA1*0301 suggesting that this is one of the older and more established HLA DQB1* alleles in Eurasia. The intron structure of DQB1 suggest that DQB1*0301 DQB1*0302/*0303 split occurred before DQB1*0302/*0303, the distribution of *03 in Africa suggest that recombination DQA1*03:DQB1*0301 are primarily the result of recombination events that have occurred in Africa. A recent study of myasthenia gravis in Houston confirms the presence of A*0505:B*0301 in Nigeria. B1*0301 and A1*03 haplotypes are found at relatively high frequencies in SE Asia and Austronesia, also indicating that it is well established in the exo-African population.
The DQ7.3 haplotype can be formed by DQA1*0301:DQB1*0301, DQA1*0302:DQB1*0301, DQA1*0303:DQB1*0301. In the west, the DQA1*0303:DQB1*0301 haplotype appears to be more common.The gene products of all 3 function similarly and subunits are interchangeable. In the literature, older DNA tests recognize DQA1*0303 as DQA1*0302, and still oldest DNA tests recognize all three as DQA1*03 or DQA1*0301.
DQA1*0303:DQB1*0301 may be involved in narcolepsy.[4] DQ7.3 appears to be associated with oral ulcerations and gingival disease [5]
| freq | |||
| ref. | Population | (%) | |
| Chukotka Chukchi (Siberia) | 9.5 | ||
| Gvaysugi Udegeys (Siberia) | 9.5 | ||
| Chukotka Eskimos (Siberia) | 8.7 | ||
| Polygus Evenks (Siberia) | 7.2 | ||
| NE Koryaks (Kamchatka) | 6.5 | ||
| Cameroon Saa | 4.4 | ||
| Sulamai Kets (Siberia) | 2.3 | ||
| Gambia | 1.4 | ||
| Fukuoka Japan | 1.2 | ||
| [6] | Caucasian Americans | 0.3 |
DQA1*0401:DQB1*0301 (DQ7.4) This haplotype is found in Siberia, Africa but also at low levels in Western Europe.
| freq | |||
| ref. | Population | (%) | |
| [7] | Lebanon (estimated) | 40.0 | |
| Italy Rome | 29.6 | ||
| Netherlands (2) | 15.5 | ||
| Tunisia | 14.6 | ||
| England (2) | 10.1 | ||
| South Korea | 6.8 | ||
| Congo Kinshasa Bantu | 4.4 |
The processed alpha subunit of DQA1*0505 is identical to that of DQA1*0501, but some slight differences in the association with autoimmune disease are observed, possibly as a result of linked DR and DQB1 genes. DQA1*0505 can play into celiac disease under two circumstances. First it can increase risk when DQ2.5 is present, although current studies indicate that it marginally increases risk relative to DQB1*0202 in DQ2.5 cis haplotype. DQA1*0505, without DQ2, is found in a small percentage of coeliac disease (without DQ2 or DQ8).[10]
DQ7.5 is found also high in frequency in the new world, but with DR types less commonly encountered in the old world. DQA1*05 allele is not clear in the new world. DQB1*0301 may be under current positive selection in the human population, at least in areas where DQ2.5 and DQ8 are high, as it confers resistance to type 1 diabetes. For hepatitis type B, DQ7 is associated with persistence but for C, DQ7 is associated with clearance.[11] DQA1*0505, DQB1*0301 appear to increase the risk for melanoma in the Spanish population however this may have a linkage to more recent fair skinned migrants. DQB1*0301 is also associated with allergic fungal sinusitis, human papillomavirus (HPV) induced warts, limited cutaneous systemic sclerosis in Africans, and primary sclerosing cholangitis in Southern Europeans. DQB1*0301 is also predisposing in narcolepsy.[4] DQB1*0301 does not to play a role in any frequently occurring autoimmune disease and its presence in the near east and suppressed frequencies of coeliac disease and Type 1 diabetes in these regions is suggestive that it has a positive selection in Post-Mesolithic cereal based societies in the Western Eurasia.
DQB1*0301 appears to be more associated with early onset myastheniagravis in Japanese than DQ8, and was also found along with DQB1*0304 to be associated with Chinese MG. DQ7 or associated DR types may play a role in rheumatoid arthritis. In celiac disease the DQ7 (A*0505/1) can mediate celiac disease when HLA DQ2.2 is also present. HLA DQB1*0301 in Turks is associated with Thymoma but the risk may be associated with HLA class I loci.
| freq | |||
| ref. | Population | (%) | |
| Java Yogyakarta | 48.1 | ||
| Kiribati | 37.9 | ||
| Nauru | 28.4 | ||
| Harbin City (Manchuria, China) | 12.8 | ||
| Thailand | 12.7 | ||
| South Korean (5) | 4.4 | ||
| China Beijing and Xian | 3.5 | ||
| Japan | 3.0 | ||
| India Bombay | 1.7 | ||
| England Caucasoid | 0.6 | ||
| Italy Central | 0.6 | ||
| Algeria1 | 0.5 | ||
| Cameroon | 0.4 |
DQA1*0601:DQB1*0301 (DQ7.6) is a globally rare haplotype, however it is found at high frequencies in the South Pacific and along the West Pacific rim. DQB1*0301 appears to be uniquely linked to DQA1*0601. DQ7.6 is positively associated with asthma,[12] pauciarticular juvenile arthritis without anti-nuclear antibodies,[13] DQ7.6 is negatively associated (Protective against) juvenile diabetes,[14] liver and spleen disease in Schistosoma japonicum infection,[15] pulmonary tuberculosis.[16]